IL6 and autoimmune disease: The RANKL-dependent regulation of osteoclast formation by IL-6/sIL-6R might reflect pathological processes of the local microenvironment in autoimmune diseases associated with bone destruction, such as RA, and whether this effect is stimulatory or inhibitory may be dependent on disease stage.